Waters Andrew Alliance

Acquired

Founded 2011 · $14.0M raised

Employees
51–200
Founded
2011
Business Model
B2B
Total Funding
$14.0M
Last Round
$14.0M Series CJun 2018
Rounds
2

About

Andrew Alliance, operating under Waters Corporation after its acquisition, designs and manufactures the Andrew+ pipetting robot and OneLab cloud-connected lab software for life science laboratories. The company's platform automates complete liquid handling workflows — from serial dilutions to sample preparation — using standard laboratory pipettes and labware, ensuring reproducibility and full audit traceability. Its customers include pharmaceutical, bioprocessing, genomics, and clinical research labs. Andrew Alliance was founded in Geneva in 2011 and acquired by Waters Corporation (NYSE: WAT) to expand its lab automation portfolio.

Summary

Waters Andrew Alliance is a Biotech company, founded in 2011. It has raised $14.0M in total across 2 rounds, most recently a $14.0M Series C round in Jun 2018. Investors include Waters Corporation, Omega Funds and Tecan Group.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionJan 2020
$80.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies